Covidien gets FDA nod for embolic protection device

The FDA has granted Covidien 510(k) clearance for its SpiderFX device, which is used in combination with plaque excision to treat severely calcified lesions in arteries found in the lower extremities. The device is the only embolic protection device cleared in the U.S. for lower extremity use, the company said in a release.

View Full Article in:

Mass High Tech (Boston) · Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD